0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Peptide APIs Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-29R17243
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Therapeutic Peptide APIs Market Research Report 2024
BUY CHAPTERS

Global Therapeutic Peptide APIs Market Research Report 2024

Code: QYRE-Auto-29R17243
Report
June 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Therapeutic Peptide APIs Market

Therapeutic peptide APIs (Active Pharmaceutical Ingredients) are specific peptides developed for use in pharmaceutical drugs to treat various diseases and medical conditions. Peptides are short chains of amino acids linked by peptide bonds, and they can mimic or influence biological processes, making them suitable for therapeutic purposes.
The global Therapeutic Peptide APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Therapeutic Peptide APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Therapeutic Peptide APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Therapeutic Peptide APIs include Bachem, GenScript, AmbioPharm, Limitless Biotech, CPC Scientific, PolyPeptide, CordenPharma, Lonza, Aspen API, Syngene, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Peptide APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Peptide APIs.
The Therapeutic Peptide APIs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Therapeutic Peptide APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Peptide APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Therapeutic Peptide APIs Market Report

Report Metric Details
Report Name Therapeutic Peptide APIs Market
Segment by Type
  • Bioactive Peptides
  • Synthetic Peptides
Segment by Application
  • Pharmaceuticals
  • Scientific Research
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bachem, GenScript, AmbioPharm, Limitless Biotech, CPC Scientific, PolyPeptide, CordenPharma, Lonza, Aspen API, Syngene, USV Peptides, Bio Basic, JPT Peptide Technologies, ScinoPharm, Piramal Pharma, Jiangsu Sinopep-Allsino Biopharmaceutical, Cheng Du Sheng Nuo Biotec, Hybio Pharmaceutical, Hainan Shuangcheng Pharmaceuticals, Guangdong Jianyuan Pharmaceutical, Zhejiang Peptites Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Therapeutic Peptide APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Therapeutic Peptide APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Therapeutic Peptide APIs Market report?

Ans: The main players in the Therapeutic Peptide APIs Market are Bachem, GenScript, AmbioPharm, Limitless Biotech, CPC Scientific, PolyPeptide, CordenPharma, Lonza, Aspen API, Syngene, USV Peptides, Bio Basic, JPT Peptide Technologies, ScinoPharm, Piramal Pharma, Jiangsu Sinopep-Allsino Biopharmaceutical, Cheng Du Sheng Nuo Biotec, Hybio Pharmaceutical, Hainan Shuangcheng Pharmaceuticals, Guangdong Jianyuan Pharmaceutical, Zhejiang Peptites Biotech

What are the Application segmentation covered in the Therapeutic Peptide APIs Market report?

Ans: The Applications covered in the Therapeutic Peptide APIs Market report are Pharmaceuticals, Scientific Research, Other

What are the Type segmentation covered in the Therapeutic Peptide APIs Market report?

Ans: The Types covered in the Therapeutic Peptide APIs Market report are Bioactive Peptides, Synthetic Peptides

1 Therapeutic Peptide APIs Market Overview
1.1 Product Definition
1.2 Therapeutic Peptide APIs by Type
1.2.1 Global Therapeutic Peptide APIs Market Value Comparison by Type (2024-2030)
1.2.2 Bioactive Peptides
1.2.3 Synthetic Peptides
1.3 Therapeutic Peptide APIs by Application
1.3.1 Global Therapeutic Peptide APIs Market Value by Application (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Other
1.4 Global Therapeutic Peptide APIs Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Peptide APIs Revenue 2019-2030
1.4.2 Global Therapeutic Peptide APIs Sales 2019-2030
1.4.3 Global Therapeutic Peptide APIs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Peptide APIs Market Competition by Manufacturers
2.1 Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Peptide APIs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Peptide APIs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Therapeutic Peptide APIs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Peptide APIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Peptide APIs, Product Type & Application
2.7 Global Key Manufacturers of Therapeutic Peptide APIs, Date of Enter into This Industry
2.8 Global Therapeutic Peptide APIs Market Competitive Situation and Trends
2.8.1 Global Therapeutic Peptide APIs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Therapeutic Peptide APIs Players Market Share by Revenue
2.8.3 Global Therapeutic Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Therapeutic Peptide APIs Market Scenario by Region
3.1 Global Therapeutic Peptide APIs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Peptide APIs Sales by Region: 2019-2030
3.2.1 Global Therapeutic Peptide APIs Sales by Region: 2019-2024
3.2.2 Global Therapeutic Peptide APIs Sales by Region: 2025-2030
3.3 Global Therapeutic Peptide APIs Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Peptide APIs Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Peptide APIs Revenue by Region: 2025-2030
3.4 North America Therapeutic Peptide APIs Market Facts & Figures by Country
3.4.1 North America Therapeutic Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Peptide APIs Sales by Country (2019-2030)
3.4.3 North America Therapeutic Peptide APIs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Therapeutic Peptide APIs Market Facts & Figures by Country
3.5.1 Europe Therapeutic Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Peptide APIs Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Peptide APIs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Peptide APIs Market Facts & Figures by Region
3.6.1 Asia Pacific Therapeutic Peptide APIs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Peptide APIs Sales by Region (2019-2030)
3.6.3 Asia Pacific Therapeutic Peptide APIs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Therapeutic Peptide APIs Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Peptide APIs Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Peptide APIs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Therapeutic Peptide APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Peptide APIs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Peptide APIs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic Peptide APIs Sales by Type (2019-2030)
4.1.1 Global Therapeutic Peptide APIs Sales by Type (2019-2024)
4.1.2 Global Therapeutic Peptide APIs Sales by Type (2025-2030)
4.1.3 Global Therapeutic Peptide APIs Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Peptide APIs Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Peptide APIs Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Peptide APIs Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Peptide APIs Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Peptide APIs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Peptide APIs Sales by Application (2019-2030)
5.1.1 Global Therapeutic Peptide APIs Sales by Application (2019-2024)
5.1.2 Global Therapeutic Peptide APIs Sales by Application (2025-2030)
5.1.3 Global Therapeutic Peptide APIs Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Peptide APIs Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Peptide APIs Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Peptide APIs Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Peptide APIs Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Peptide APIs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bachem
6.1.1 Bachem Company Information
6.1.2 Bachem Description and Business Overview
6.1.3 Bachem Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bachem Therapeutic Peptide APIs Product Portfolio
6.1.5 Bachem Recent Developments/Updates
6.2 GenScript
6.2.1 GenScript Company Information
6.2.2 GenScript Description and Business Overview
6.2.3 GenScript Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GenScript Therapeutic Peptide APIs Product Portfolio
6.2.5 GenScript Recent Developments/Updates
6.3 AmbioPharm
6.3.1 AmbioPharm Company Information
6.3.2 AmbioPharm Description and Business Overview
6.3.3 AmbioPharm Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AmbioPharm Therapeutic Peptide APIs Product Portfolio
6.3.5 AmbioPharm Recent Developments/Updates
6.4 Limitless Biotech
6.4.1 Limitless Biotech Company Information
6.4.2 Limitless Biotech Description and Business Overview
6.4.3 Limitless Biotech Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Limitless Biotech Therapeutic Peptide APIs Product Portfolio
6.4.5 Limitless Biotech Recent Developments/Updates
6.5 CPC Scientific
6.5.1 CPC Scientific Company Information
6.5.2 CPC Scientific Description and Business Overview
6.5.3 CPC Scientific Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CPC Scientific Therapeutic Peptide APIs Product Portfolio
6.5.5 CPC Scientific Recent Developments/Updates
6.6 PolyPeptide
6.6.1 PolyPeptide Company Information
6.6.2 PolyPeptide Description and Business Overview
6.6.3 PolyPeptide Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 PolyPeptide Therapeutic Peptide APIs Product Portfolio
6.6.5 PolyPeptide Recent Developments/Updates
6.7 CordenPharma
6.7.1 CordenPharma Company Information
6.7.2 CordenPharma Description and Business Overview
6.7.3 CordenPharma Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 CordenPharma Therapeutic Peptide APIs Product Portfolio
6.7.5 CordenPharma Recent Developments/Updates
6.8 Lonza
6.8.1 Lonza Company Information
6.8.2 Lonza Description and Business Overview
6.8.3 Lonza Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lonza Therapeutic Peptide APIs Product Portfolio
6.8.5 Lonza Recent Developments/Updates
6.9 Aspen API
6.9.1 Aspen API Company Information
6.9.2 Aspen API Description and Business Overview
6.9.3 Aspen API Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aspen API Therapeutic Peptide APIs Product Portfolio
6.9.5 Aspen API Recent Developments/Updates
6.10 Syngene
6.10.1 Syngene Company Information
6.10.2 Syngene Description and Business Overview
6.10.3 Syngene Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Syngene Therapeutic Peptide APIs Product Portfolio
6.10.5 Syngene Recent Developments/Updates
6.11 USV Peptides
6.11.1 USV Peptides Company Information
6.11.2 USV Peptides Description and Business Overview
6.11.3 USV Peptides Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 USV Peptides Therapeutic Peptide APIs Product Portfolio
6.11.5 USV Peptides Recent Developments/Updates
6.12 Bio Basic
6.12.1 Bio Basic Company Information
6.12.2 Bio Basic Description and Business Overview
6.12.3 Bio Basic Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bio Basic Therapeutic Peptide APIs Product Portfolio
6.12.5 Bio Basic Recent Developments/Updates
6.13 JPT Peptide Technologies
6.13.1 JPT Peptide Technologies Company Information
6.13.2 JPT Peptide Technologies Description and Business Overview
6.13.3 JPT Peptide Technologies Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolio
6.13.5 JPT Peptide Technologies Recent Developments/Updates
6.14 ScinoPharm
6.14.1 ScinoPharm Company Information
6.14.2 ScinoPharm Description and Business Overview
6.14.3 ScinoPharm Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ScinoPharm Therapeutic Peptide APIs Product Portfolio
6.14.5 ScinoPharm Recent Developments/Updates
6.15 Piramal Pharma
6.15.1 Piramal Pharma Company Information
6.15.2 Piramal Pharma Description and Business Overview
6.15.3 Piramal Pharma Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Piramal Pharma Therapeutic Peptide APIs Product Portfolio
6.15.5 Piramal Pharma Recent Developments/Updates
6.16 Jiangsu Sinopep-Allsino Biopharmaceutical
6.16.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
6.16.2 Jiangsu Sinopep-Allsino Biopharmaceutical Description and Business Overview
6.16.3 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolio
6.16.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments/Updates
6.17 Cheng Du Sheng Nuo Biotec
6.17.1 Cheng Du Sheng Nuo Biotec Company Information
6.17.2 Cheng Du Sheng Nuo Biotec Description and Business Overview
6.17.3 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolio
6.17.5 Cheng Du Sheng Nuo Biotec Recent Developments/Updates
6.18 Hybio Pharmaceutical
6.18.1 Hybio Pharmaceutical Company Information
6.18.2 Hybio Pharmaceutical Description and Business Overview
6.18.3 Hybio Pharmaceutical Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolio
6.18.5 Hybio Pharmaceutical Recent Developments/Updates
6.19 Hainan Shuangcheng Pharmaceuticals
6.19.1 Hainan Shuangcheng Pharmaceuticals Company Information
6.19.2 Hainan Shuangcheng Pharmaceuticals Description and Business Overview
6.19.3 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolio
6.19.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
6.20 Guangdong Jianyuan Pharmaceutical
6.20.1 Guangdong Jianyuan Pharmaceutical Company Information
6.20.2 Guangdong Jianyuan Pharmaceutical Description and Business Overview
6.20.3 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolio
6.20.5 Guangdong Jianyuan Pharmaceutical Recent Developments/Updates
6.21 Zhejiang Peptites Biotech
6.21.1 Zhejiang Peptites Biotech Company Information
6.21.2 Zhejiang Peptites Biotech Description and Business Overview
6.21.3 Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolio
6.21.5 Zhejiang Peptites Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Peptide APIs Industry Chain Analysis
7.2 Therapeutic Peptide APIs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Peptide APIs Production Mode & Process
7.4 Therapeutic Peptide APIs Sales and Marketing
7.4.1 Therapeutic Peptide APIs Sales Channels
7.4.2 Therapeutic Peptide APIs Distributors
7.5 Therapeutic Peptide APIs Customers
8 Therapeutic Peptide APIs Market Dynamics
8.1 Therapeutic Peptide APIs Industry Trends
8.2 Therapeutic Peptide APIs Market Drivers
8.3 Therapeutic Peptide APIs Market Challenges
8.4 Therapeutic Peptide APIs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Therapeutic Peptide APIs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Therapeutic Peptide APIs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Therapeutic Peptide APIs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Therapeutic Peptide APIs Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Therapeutic Peptide APIs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Therapeutic Peptide APIs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Therapeutic Peptide APIs Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Therapeutic Peptide APIs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Therapeutic Peptide APIs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Therapeutic Peptide APIs, Product Type & Application
 Table 12. Global Key Manufacturers of Therapeutic Peptide APIs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Therapeutic Peptide APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Peptide APIs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Therapeutic Peptide APIs Sales by Region (2019-2024) & (Tons)
 Table 18. Global Therapeutic Peptide APIs Sales Market Share by Region (2019-2024)
 Table 19. Global Therapeutic Peptide APIs Sales by Region (2025-2030) & (Tons)
 Table 20. Global Therapeutic Peptide APIs Sales Market Share by Region (2025-2030)
 Table 21. Global Therapeutic Peptide APIs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Therapeutic Peptide APIs Revenue Market Share by Region (2019-2024)
 Table 23. Global Therapeutic Peptide APIs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Therapeutic Peptide APIs Revenue Market Share by Region (2025-2030)
 Table 25. North America Therapeutic Peptide APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
 Table 27. North America Therapeutic Peptide APIs Sales by Country (2025-2030) & (Tons)
 Table 28. North America Therapeutic Peptide APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Therapeutic Peptide APIs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Therapeutic Peptide APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Therapeutic Peptide APIs Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Therapeutic Peptide APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Therapeutic Peptide APIs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Therapeutic Peptide APIs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Therapeutic Peptide APIs Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Therapeutic Peptide APIs Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Therapeutic Peptide APIs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Therapeutic Peptide APIs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Therapeutic Peptide APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Therapeutic Peptide APIs Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Therapeutic Peptide APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Therapeutic Peptide APIs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Therapeutic Peptide APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Therapeutic Peptide APIs Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Therapeutic Peptide APIs Sales (Tons) by Type (2019-2024)
 Table 51. Global Therapeutic Peptide APIs Sales (Tons) by Type (2025-2030)
 Table 52. Global Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
 Table 53. Global Therapeutic Peptide APIs Sales Market Share by Type (2025-2030)
 Table 54. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Therapeutic Peptide APIs Revenue Market Share by Type (2019-2024)
 Table 57. Global Therapeutic Peptide APIs Revenue Market Share by Type (2025-2030)
 Table 58. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2019-2024)
 Table 59. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2025-2030)
 Table 60. Global Therapeutic Peptide APIs Sales (Tons) by Application (2019-2024)
 Table 61. Global Therapeutic Peptide APIs Sales (Tons) by Application (2025-2030)
 Table 62. Global Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
 Table 63. Global Therapeutic Peptide APIs Sales Market Share by Application (2025-2030)
 Table 64. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Therapeutic Peptide APIs Revenue Market Share by Application (2019-2024)
 Table 67. Global Therapeutic Peptide APIs Revenue Market Share by Application (2025-2030)
 Table 68. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2019-2024)
 Table 69. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2025-2030)
 Table 70. Bachem Company Information
 Table 71. Bachem Description and Business Overview
 Table 72. Bachem Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. Bachem Therapeutic Peptide APIs Product
 Table 74. Bachem Recent Developments/Updates
 Table 75. GenScript Company Information
 Table 76. GenScript Description and Business Overview
 Table 77. GenScript Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. GenScript Therapeutic Peptide APIs Product
 Table 79. GenScript Recent Developments/Updates
 Table 80. AmbioPharm Company Information
 Table 81. AmbioPharm Description and Business Overview
 Table 82. AmbioPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. AmbioPharm Therapeutic Peptide APIs Product
 Table 84. AmbioPharm Recent Developments/Updates
 Table 85. Limitless Biotech Company Information
 Table 86. Limitless Biotech Description and Business Overview
 Table 87. Limitless Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. Limitless Biotech Therapeutic Peptide APIs Product
 Table 89. Limitless Biotech Recent Developments/Updates
 Table 90. CPC Scientific Company Information
 Table 91. CPC Scientific Description and Business Overview
 Table 92. CPC Scientific Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. CPC Scientific Therapeutic Peptide APIs Product
 Table 94. CPC Scientific Recent Developments/Updates
 Table 95. PolyPeptide Company Information
 Table 96. PolyPeptide Description and Business Overview
 Table 97. PolyPeptide Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. PolyPeptide Therapeutic Peptide APIs Product
 Table 99. PolyPeptide Recent Developments/Updates
 Table 100. CordenPharma Company Information
 Table 101. CordenPharma Description and Business Overview
 Table 102. CordenPharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. CordenPharma Therapeutic Peptide APIs Product
 Table 104. CordenPharma Recent Developments/Updates
 Table 105. Lonza Company Information
 Table 106. Lonza Description and Business Overview
 Table 107. Lonza Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. Lonza Therapeutic Peptide APIs Product
 Table 109. Lonza Recent Developments/Updates
 Table 110. Aspen API Company Information
 Table 111. Aspen API Description and Business Overview
 Table 112. Aspen API Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. Aspen API Therapeutic Peptide APIs Product
 Table 114. Aspen API Recent Developments/Updates
 Table 115. Syngene Company Information
 Table 116. Syngene Description and Business Overview
 Table 117. Syngene Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. Syngene Therapeutic Peptide APIs Product
 Table 119. Syngene Recent Developments/Updates
 Table 120. USV Peptides Company Information
 Table 121. USV Peptides Description and Business Overview
 Table 122. USV Peptides Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 123. USV Peptides Therapeutic Peptide APIs Product
 Table 124. USV Peptides Recent Developments/Updates
 Table 125. Bio Basic Company Information
 Table 126. Bio Basic Description and Business Overview
 Table 127. Bio Basic Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 128. Bio Basic Therapeutic Peptide APIs Product
 Table 129. Bio Basic Recent Developments/Updates
 Table 130. JPT Peptide Technologies Company Information
 Table 131. JPT Peptide Technologies Description and Business Overview
 Table 132. JPT Peptide Technologies Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 133. JPT Peptide Technologies Therapeutic Peptide APIs Product
 Table 134. JPT Peptide Technologies Recent Developments/Updates
 Table 135. ScinoPharm Company Information
 Table 136. ScinoPharm Description and Business Overview
 Table 137. ScinoPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 138. ScinoPharm Therapeutic Peptide APIs Product
 Table 139. ScinoPharm Recent Developments/Updates
 Table 140. Piramal Pharma Company Information
 Table 141. Piramal Pharma Description and Business Overview
 Table 142. Piramal Pharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 143. Piramal Pharma Therapeutic Peptide APIs Product
 Table 144. Piramal Pharma Recent Developments/Updates
 Table 145. Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
 Table 146. Jiangsu Sinopep-Allsino Biopharmaceutical Description and Business Overview
 Table 147. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product
 Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments/Updates
 Table 150. Cheng Du Sheng Nuo Biotec Company Information
 Table 151. Cheng Du Sheng Nuo Biotec Description and Business Overview
 Table 152. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 153. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product
 Table 154. Cheng Du Sheng Nuo Biotec Recent Developments/Updates
 Table 155. Hybio Pharmaceutical Company Information
 Table 156. Hybio Pharmaceutical Description and Business Overview
 Table 157. Hybio Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 158. Hybio Pharmaceutical Therapeutic Peptide APIs Product
 Table 159. Hybio Pharmaceutical Recent Developments/Updates
 Table 160. Hainan Shuangcheng Pharmaceuticals Company Information
 Table 161. Hainan Shuangcheng Pharmaceuticals Description and Business Overview
 Table 162. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 163. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product
 Table 164. Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
 Table 165. Guangdong Jianyuan Pharmaceutical Company Information
 Table 166. Guangdong Jianyuan Pharmaceutical Description and Business Overview
 Table 167. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 168. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product
 Table 169. Guangdong Jianyuan Pharmaceutical Recent Developments/Updates
 Table 170. Zhejiang Peptites Biotech Company Information
 Table 171. Zhejiang Peptites Biotech Description and Business Overview
 Table 172. Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 173. Zhejiang Peptites Biotech Therapeutic Peptide APIs Product
 Table 174. Zhejiang Peptites Biotech Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Therapeutic Peptide APIs Distributors List
 Table 178. Therapeutic Peptide APIs Customers List
 Table 179. Therapeutic Peptide APIs Market Trends
 Table 180. Therapeutic Peptide APIs Market Drivers
 Table 181. Therapeutic Peptide APIs Market Challenges
 Table 182. Therapeutic Peptide APIs Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Therapeutic Peptide APIs
 Figure 2. Global Therapeutic Peptide APIs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Therapeutic Peptide APIs Market Share by Type: 2023 & 2030
 Figure 4. Bioactive Peptides Product Picture
 Figure 5. Synthetic Peptides Product Picture
 Figure 6. Global Therapeutic Peptide APIs Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Therapeutic Peptide APIs Market Share by Application: 2023 & 2030
 Figure 8. Pharmaceuticals
 Figure 9. Scientific Research
 Figure 10. Other
 Figure 11. Global Therapeutic Peptide APIs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Therapeutic Peptide APIs Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Therapeutic Peptide APIs Sales (2019-2030) & (Tons)
 Figure 14. Global Therapeutic Peptide APIs Average Price (US$/kg) & (2019-2030)
 Figure 15. Therapeutic Peptide APIs Report Years Considered
 Figure 16. Therapeutic Peptide APIs Sales Share by Manufacturers in 2023
 Figure 17. Global Therapeutic Peptide APIs Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Therapeutic Peptide APIs Players: Market Share by Revenue in Therapeutic Peptide APIs in 2023
 Figure 19. Therapeutic Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Therapeutic Peptide APIs Sales Market Share by Country (2019-2030)
 Figure 22. North America Therapeutic Peptide APIs Revenue Market Share by Country (2019-2030)
 Figure 23. United States Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Therapeutic Peptide APIs Sales Market Share by Country (2019-2030)
 Figure 26. Europe Therapeutic Peptide APIs Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Therapeutic Peptide APIs Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Therapeutic Peptide APIs Revenue Market Share by Region (2019-2030)
 Figure 34. China Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Therapeutic Peptide APIs Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Therapeutic Peptide APIs Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Therapeutic Peptide APIs Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Therapeutic Peptide APIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Therapeutic Peptide APIs by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Therapeutic Peptide APIs by Type (2019-2030)
 Figure 53. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Therapeutic Peptide APIs by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Therapeutic Peptide APIs by Application (2019-2030)
 Figure 56. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2019-2030)
 Figure 57. Therapeutic Peptide APIs Value Chain
 Figure 58. Therapeutic Peptide APIs Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart